Dr. Leyna Zhao profile page

Dr. Leyna Zhao is Product Marketing Director at Agilent Technologies, where she leads global strategy for cell analysis platforms, including xCELLigence Real-Time Cell Analysis (RTCA). With over 20 years of experience in molecular biology, immunology, and drug discovery, she bridges scientific innovation with market adoption across pharma and biotech sectors. Her work focuses on advancing label-free, real-time technologies that support small molecule screening, immune cell function analysis, and predictive toxicology. Dr. Zhao has been instrumental in aligning Agilent’s cell analysis solutions with emerging regulatory trends, including the FDA’s move toward non-animal testing methodologies. She holds a Ph.D. in Biochemistry and has authored 20+ peer-reviewed publications. Her expertise spans translational research, assay development, and strategic product positioning in the life sciences industry.